Literature DB >> 17261834

Atherothrombotic events and clopidogrel therapy.

Craig S McLachlan, Stacey K H Tay, Zakaria Almsherqi, Shu-Hui Chia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17261834      PMCID： PMC1780104          DOI： 10.1503/cmaj.1060153

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Late stent thrombosis (> 1 year) following clopidogrel withdrawal after brachytherapy treatment: need to assess aspirin resistance?

Authors:  Pilar Jiménez-Quevedo; Dominick J Angiolillo; Esther Bernardo; Manel Sabaté
Journal:  Catheter Cardiovasc Interv       Date:  2004-05       Impact factor: 2.692

2.  Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.

Authors:  Jung-Won Suh; Bon-Kwon Koo; Shu-Ying Zhang; Kyung-Woo Park; Joo-Youn Cho; In-Jin Jang; Dong-Soon Lee; Dae-Won Sohn; Myoung-Mook Lee; Hyo-Soo Kim
Journal:  CMAJ       Date:  2006-06-06       Impact factor: 8.262

3.  More on: enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized cross-over trial.

Authors:  Z A Almsherqi; C S McLachlan; S M Sharef
Journal:  J Thromb Haemost       Date:  2006-07       Impact factor: 5.824

4.  Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease.

Authors:  Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Celia Ramírez; Manel Sabaté; Pilar Jimenez-Quevedo; Rosana Hernández; Raul Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Marco A Costa; Theodore A Bass; Carlos Macaya
Journal:  Diabetes       Date:  2006-03       Impact factor: 9.461

5.  Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study.

Authors:  Giuseppe G L Biondi-Zoccai; Pierfrancesco Agostoni; Giuseppe M Sangiorgi; Ioannis Iakovou; David Antoniucci; Eberhard Grube; Corrado Tamburino; Carlo Di Mario; Bernhard Reimers; Iassen Michev; Omer Goktekin; Flavio Airoldi; Alaide Chieffo; John Cosgrave; Worawut Tassanawiwat; Antonio Colombo
Journal:  Int J Cardiol       Date:  2006-04-14       Impact factor: 4.164
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.